News | October 07, 2025
IMCD unveils future of beauty at In-Cosmetics Latin America 2025
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Targeting a 10% reduction in energy and water consumption, and a 30% cut in carbon emissions across facilities by 2025
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
The facility has been designed with a dual focus on efficiency and sustainability
It will focus on interface between API and formulation manufacturing, reducing carbon footprint in formulation production, creating intellectual property, training next-generation scientists, and setting new industry benchmarks
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
